Hiroshi Nagai Selected Research

SHPS-1-Fc fusion protein

4/2006

Engagement of CD47 inhibits the contact hypersensitivity response via the suppression of motility and B7 expression by Langerhans cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroshi Nagai Research Topics

Disease

18	Neoplasms (Cancer) 01/2021 - 09/2002
12	Melanoma (Melanoma, Malignant) 01/2018 - 06/2002
5	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2018 - 01/2012
4	Vitiligo 11/2020 - 10/2004
4	Inflammation (Inflammations) 01/2018 - 01/2012
3	Carcinoma (Carcinomatosis) 01/2021 - 09/2006
3	Infections 01/2017 - 11/2004
2	Adenoma (Adenomas) 12/2021 - 01/2021
2	Fibrosis (Cirrhosis) 01/2021 - 06/2014
2	Dermatitis 08/2020 - 01/2015
2	Contact Dermatitis (Eczema, Contact) 08/2020 - 04/2006
2	Tuberous Sclerosis (Bourneville's Disease) 08/2020 - 01/2018
2	Erythema 08/2020 - 01/2007
2	Allergic Contact Dermatitis 02/2018 - 05/2010
2	Macular Degeneration (Age-Related Maculopathy) 01/2018 - 12/2014
2	Hyperplasia 05/2017 - 06/2014
2	Bites and Stings (Sting) 01/2015 - 01/2015
2	Leukemia 01/2008 - 07/2004
2	Ischemia 04/2005 - 06/2004
2	Myocardial Infarction 04/2005 - 06/2004
2	Experimental Melanoma 10/2004 - 09/2002
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Pityriasis Rubra Pilaris 11/2020
1	Pruritus (Itching) 08/2020
1	Acne Vulgaris 08/2020
1	Lymphoma (Lymphomas) 01/2019
1	Geographic Atrophy 01/2018
1	Blindness (Hysterical Blindness) 01/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018
1	Angiofibroma 01/2018
1	Pancreatitis 01/2018
1	Anaphylaxis (Anaphylactic Shock) 08/2017
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2017
1	Pneumothorax 01/2017
1	Pain (Aches) 01/2015
1	Neoplasm Metastasis (Metastasis) 01/2015

Drug/Important Bio-Agent (IBA)

6	Interleukin-27 (Interleukin 27)IBA 01/2013 - 06/2006
5	Protein Kinase CIBA 08/2013 - 06/2002
4	Interleukin-23 (Interleukin 23)IBA 05/2017 - 06/2006
4	CytokinesIBA 06/2014 - 10/2004
4	Proteins (Proteins, Gene)FDA Link 01/2013 - 06/2004
3	Biomarkers (Surrogate Marker)IBA 12/2021 - 07/2004
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 01/2012
3	InterferonsIBA 01/2020 - 09/2002
3	Interleukin-18 (Interleukin 18)IBA 05/2017 - 09/2002
3	debromoaplysiatoxinIBA 01/2016 - 06/2012
3	CarcinogensIBA 08/2013 - 06/2009
3	aplysiatoxinIBA 01/2011 - 06/2009
2	MicroRNAs (MicroRNA)IBA 12/2021 - 01/2021
2	trans-sodium crocetinate (crocetin)IBA 08/2020 - 01/2018
2	Sirolimus (Rapamycin)FDA Link 08/2020 - 01/2018
2	Pharmaceutical PreparationsIBA 08/2020 - 11/2016
2	Infliximab (Remicade)FDA Link 11/2016 - 01/2011
2	VenomsIBA 01/2015 - 11/2005
2	IsoenzymesIBA 08/2013 - 10/2010
2	BryostatinsIBA 06/2012 - 06/2009
2	ChemokinesIBA 01/2012 - 09/2002
2	Biological ProductsIBA 01/2011 - 10/2010
2	Protein Kinases (Protein Kinase)IBA 01/2011 - 10/2010
2	Phorbol EstersIBA 01/2011 - 06/2009
2	Hydroxyl RadicalIBA 10/2010 - 06/2004
2	Interleukin-12 (IL 12)IBA 09/2010 - 10/2004
2	Antineoplastic Agents (Antineoplastics)IBA 06/2009 - 05/2008
2	interleukin-21 (interleukin 21)IBA 10/2007 - 09/2006
2	Phosphotransferases (Kinase)IBA 06/2004 - 06/2002
2	phospholipase D1IBA 11/2003 - 06/2002
1	Tumor Biomarkers (Tumor Markers)IBA 12/2021
1	ORALIT (ORS)IBA 01/2021
1	CosmeticsIBA 11/2020
1	rhododendrolIBA 11/2020
1	hydroquinone (Esoterica)FDA Link 11/2020
1	guselkumabIBA 11/2020
1	Ether (Diethyl Ether)IBA 11/2020
1	Fas Ligand Protein (Fas Ligand)IBA 01/2020
1	oscillatoxin IIBA 01/2019
1	Local Anti-Infective Agents (Antiseptics)IBA 02/2018
1	olanexidine gluconateIBA 02/2018
1	alpha2 Subunit Collagen Type IIBA 01/2018
1	Retinaldehyde (Retinal)IBA 01/2018
1	Retroelements (Retrotransposon)IBA 01/2018
1	TOR Serine-Threonine KinasesIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	InflammasomesIBA 01/2018
1	ElementsIBA 01/2018
1	Imiquimod (Aldara)FDA LinkGeneric 01/2018
1	Palmitic Acid (Hexadecanoic Acid)IBA 01/2018
1	Hair DyesIBA 08/2017
1	Basic Blue 99IBA 08/2017
1	InterleukinsIBA 05/2017
1	Adalimumab (Humira)FDA Link 11/2016
1	Sitagliptin Phosphate (Januvia)FDA Link 11/2015
1	3- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA 11/2015
1	Hypoglycemic Agents (Hypoglycemics)IBA 11/2015
1	Methotrexate (Mexate)FDA LinkGeneric 01/2015
1	pazopanib FDA Link 01/2015

Therapy/Procedure

6	Immunotherapy 07/2014 - 10/2004
4	Therapeutics 11/2016 - 09/2006
1	Total Parenteral Nutrition 01/2017
1	Punctures 01/2017
1	Catheters 01/2017